Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Richard A. Young currently holds 170,010 shares of Omega Therapeutics, Inc. (OMGA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard A. Young has been a net seller of OMGA stock. They have purchased $25.0K and sold $1.6M worth of shares.
Richard A. Young's most recent insider trade was on Sep 11, 2025, when they purchased 15,151 shares at $1.65 per share.
Richard A. Young serves as Executive at Omega Therapeutics, Inc. (OMGA). They have executed 39 insider transactions totaling $1.7M over their tenure at the company.
Richard A. Young holds the position of Executive at Omega Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Richard A. Young has shown a selling trading pattern, with $25.0K in total purchases and $1.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Richard A. Young was on Aug 16, 2019, when they sold $227.0K worth of SYRS shares. This transaction involved 22,700 shares at $10.00 per share.
Richard A. Young currently owns 170,010 shares of Omega Therapeutics, Inc. (OMGA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Richard A. Young's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Richard A. Young has 39 Form 4 filings on record as an insider at Omega Therapeutics, Inc..
Set alerts for Richard A. Young and 40,000+ other insiders.